Optimizing electrical efficacy of leadless cardiac resynchronization therapy and leadless left ventricular septal pacing: Insights on left and right ventricular activation from electrocardiographic imaging

IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Nadeev Wijesuriya MBBS , Marina Strocchi PhD , Mark Elliott MBBS, PhD , Vishal Mehta MBBS , Felicity De Vere MBBS , Sandra Howell MBBS , Nilanka Mannakkara MBBS , Baldeep S. Sidhu MBBS, PhD , Jane Kwan MSc , Paolo Bosco MBBS , Steven A. Niederer DPhil , Christopher A. Rinaldi MBBS, MD, FHRS
{"title":"Optimizing electrical efficacy of leadless cardiac resynchronization therapy and leadless left ventricular septal pacing: Insights on left and right ventricular activation from electrocardiographic imaging","authors":"Nadeev Wijesuriya MBBS ,&nbsp;Marina Strocchi PhD ,&nbsp;Mark Elliott MBBS, PhD ,&nbsp;Vishal Mehta MBBS ,&nbsp;Felicity De Vere MBBS ,&nbsp;Sandra Howell MBBS ,&nbsp;Nilanka Mannakkara MBBS ,&nbsp;Baldeep S. Sidhu MBBS, PhD ,&nbsp;Jane Kwan MSc ,&nbsp;Paolo Bosco MBBS ,&nbsp;Steven A. Niederer DPhil ,&nbsp;Christopher A. Rinaldi MBBS, MD, FHRS","doi":"10.1016/j.hroo.2024.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Leadless cardiac resynchronization therapy (CRT) is an emerging heart failure treatment. An implanted electrode delivers lateral or septal endocardial left ventricular (LV) pacing (LVP) upon detection of a right ventricular (RV) pacing stimulus from a coimplanted device, thus generating biventricular pacing (BiVP). Electrical efficacy data regarding this therapy, particularly leadless LV septal pacing (LVSP) for potential conduction system capture, are limited.</p></div><div><h3>Objectives</h3><p>The purpose of this study was to evaluate the acute performance of leadless CRT using electrocardiographic imaging (ECGi) and assess the optimal pacing modality (OPM) of LVSP on the basis of RV and LV activation.</p></div><div><h3>Methods</h3><p>Ten WiSE-CRT recipients underwent an ECGi study testing: RV pacing, BiVP, LVP only, and LVP with an optimized atrioventricular delay (LV-OPT). BiV, LV, and RV activation times (shortest time taken to activate 90% of the ventricles [BIVAT-90], shortest time taken to activate 95% of the LV, and shortest time taken to activate 90% of the RV) plus LV and BiV dyssynchrony index (standard deviation of LV activation times and standard deviation of all activation times) were calculated from reconstructed epicardial electrograms. The individual OPM yielding the greatest improvement from baseline was determined.</p></div><div><h3>Results</h3><p>BiVP generated a 23.7% improvement in BiVAT-90 (<em>P</em> = .002). An improvement of 43.3% was observed at the OPM (<em>P</em> = .0001), primarily through reductions in shortest time taken to activate 90% of the RV. At the OPM, BiVAT-90 improved in patients with lateral (43.3%; <em>P</em> = .0001; n = 5) and septal (42.4%; <em>P</em> = .009; n = 5) LV implants. The OPM varied by individual. LVP and LV-OPT were mostly superior in patients with LVSP, and in those with sinus rhythm and left bundle branch block (n = 4).</p></div><div><h3>Conclusion</h3><p>Leadless CRT significantly improves acute ECGi-derived activation and dyssynchrony metrics. Using an individualized OPM improves efficacy in selected patients. Effective LVSP is feasible, with fusion pacing at LV-OPT mitigating the potential deleterious effects on RV activation.</p></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 8","pages":"Pages 551-560"},"PeriodicalIF":2.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666501824002216/pdfft?md5=24bfc7b836daa1bb78f9e661a1efc301&pid=1-s2.0-S2666501824002216-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Rhythm O2","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666501824002216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Leadless cardiac resynchronization therapy (CRT) is an emerging heart failure treatment. An implanted electrode delivers lateral or septal endocardial left ventricular (LV) pacing (LVP) upon detection of a right ventricular (RV) pacing stimulus from a coimplanted device, thus generating biventricular pacing (BiVP). Electrical efficacy data regarding this therapy, particularly leadless LV septal pacing (LVSP) for potential conduction system capture, are limited.

Objectives

The purpose of this study was to evaluate the acute performance of leadless CRT using electrocardiographic imaging (ECGi) and assess the optimal pacing modality (OPM) of LVSP on the basis of RV and LV activation.

Methods

Ten WiSE-CRT recipients underwent an ECGi study testing: RV pacing, BiVP, LVP only, and LVP with an optimized atrioventricular delay (LV-OPT). BiV, LV, and RV activation times (shortest time taken to activate 90% of the ventricles [BIVAT-90], shortest time taken to activate 95% of the LV, and shortest time taken to activate 90% of the RV) plus LV and BiV dyssynchrony index (standard deviation of LV activation times and standard deviation of all activation times) were calculated from reconstructed epicardial electrograms. The individual OPM yielding the greatest improvement from baseline was determined.

Results

BiVP generated a 23.7% improvement in BiVAT-90 (P = .002). An improvement of 43.3% was observed at the OPM (P = .0001), primarily through reductions in shortest time taken to activate 90% of the RV. At the OPM, BiVAT-90 improved in patients with lateral (43.3%; P = .0001; n = 5) and septal (42.4%; P = .009; n = 5) LV implants. The OPM varied by individual. LVP and LV-OPT were mostly superior in patients with LVSP, and in those with sinus rhythm and left bundle branch block (n = 4).

Conclusion

Leadless CRT significantly improves acute ECGi-derived activation and dyssynchrony metrics. Using an individualized OPM improves efficacy in selected patients. Effective LVSP is feasible, with fusion pacing at LV-OPT mitigating the potential deleterious effects on RV activation.

Abstract Image

优化无导联心脏再同步疗法和无导联左室间隔起搏的电气疗效:心电图成像对左右心室激活的启示
背景无导心脏再同步治疗(CRT)是一种新兴的心衰治疗方法。植入电极在检测到来自共植入装置的右心室起搏刺激时,会发出侧向或隔膜心内膜左心室起搏(LVP),从而产生双心室起搏(BiVP)。本研究的目的是利用心电图成像(ECGi)评估无导联 CRT 的急性表现,并根据 RV 和 LV 的激活情况评估 LVSP 的最佳起搏方式(OPM):方法十名 WiSE-CRT 受试者接受了 ECGi 研究测试:RV 起搏、BiVP、仅 LVP 和带有优化房室延迟(LV-OPT)的 LVP。根据重建的心外膜电图计算双心室、左心室和右心室激活时间(激活 90% 心室所需的最短时间 [BIVAT-90]、激活 95% 左心室所需的最短时间和激活 90% 右心室所需的最短时间)以及左心室和双心室不同步指数(左心室激活时间的标准偏差和所有激活时间的标准偏差)。结果 BiVP 使 BiVAT-90 改善了 23.7%(P = .002)。OPM 的改善幅度为 43.3%(P = .0001),主要是通过缩短激活 90% RV 所需的最短时间。在 OPM,BiVAT-90 在左心室外侧植入(43.3%;P = .0001;n = 5)和室间隔植入(42.4%;P = .009;n = 5)的患者中有所改善。OPM 因人而异。LVP 和 LV-OPT 在 LVSP 患者、窦性心律和左束支传导阻滞患者(n = 4)中表现更为出色。使用个体化的 OPM 可提高选定患者的疗效。有效的 LVSP 是可行的,在 LV-OPT 融合起搏可减轻对 RV 激活的潜在有害影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart Rhythm O2
Heart Rhythm O2 Cardiology and Cardiovascular Medicine
CiteScore
3.30
自引率
0.00%
发文量
0
审稿时长
52 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信